Markets
AstraZeneca Trial Failure Puts the Pharma Giant's 'Magic' to a Rare Test
A surprise clinical trial failure has triggered a sharp sell-off in AstraZeneca shares, challenging the near-invincible reputation the pharma giant has built through years of pipeline success. Here is what the data, charts and correlations tell traders right now.